Abstract Body

Background

People living with HIV (PLWH) achieve near-normal life expectancy with combination antiretroviral therapy (cART); nonetheless, they exhibit a higher incidence of non-AIDS-defining cancers (NADCs) than the non-HIV-infected population. The mechanisms linking HIV infection to NADC development remain poorly understood. Exosomes have emerged as potential mediators of this HIV–cancer axis as both HIV-infected and tumor cells release vesicles could carry pro-oncogenic cargo. We investigated the functional role of plasma exosomes from PLWH with cancer in promoting tumor proliferation and migration.

Methods

Sixty individuals were enrolled and divided into four groups: 15 PLWH on cART with NADC (HIV+NADC+), 15 HIV-uninfected with NADC (NADC+), 15 PLWH on cART without NADC (HIV+), and 15 healthy controls (HC). HIV+NADC+ and NADC+ groups were matched for cancer type to minimize tumor-specific bias. Plasma exosomes were purified by size-exclusion chromatography and characterized using transmission electron microscopy (negative staining and immunogold labeling) and nanoparticle tracking analysis to confirm size distribution and structural integrity. Functional assays employed cancer cell lines representative of each patient’s tumor type. Cell proliferation was assessed by CFSE staining and migration by wound-healing assays at multiple time points to capture dynamic changes.

Results

Exosomes from HIV+NADC+ individuals induced significantly stronger tumor cell proliferation and migration than those from the NADC+ group. In lung cancer, proliferation increased by 13% and migration up to 3.5-fold. In hepatocellular carcinoma, proliferation increased by 12% and migration by nearly 50%. In renal cancer, proliferation increased by up to 20% and migration 3.3-fold. Additionally, integrated proteomic and transcriptomic analyses of exosomal cargo from HIV+NADC+ patients revealed upregulation of pro-oncogenic proteins and ncRNAs (QSOX1, KRT6B, COMP, SDCBP, and SNORD3A) and downregulation of anti-oncogenic ones (HGFAC and VTRNA1.1).

Conclusions

Plasma exosomes from PLWH with cancer enhance tumor cell proliferation and migration across multiple tumor types. These findings support a potential role for exosomes as mediators of tumor progression and underscore their cargo as a promising target for future diagnostic and therapeutic strategies.